Anal low risk human papillomavirus (HPV) DNA test positive
ICD-10 R85.82 is a billable code used to indicate a diagnosis of anal low risk human papillomavirus (hpv) dna test positive.
The ICD-10 code R85.82 is used to indicate a positive result for a low-risk human papillomavirus (HPV) DNA test specifically related to the anal region. HPV is a common sexually transmitted infection, with certain strains classified as low-risk, primarily associated with benign lesions such as genital warts. A positive test result indicates the presence of low-risk HPV types, which may not lead to cancer but can cause other benign conditions. Clinically, patients may present with no symptoms, or they may have visible warts or lesions. The significance of a positive low-risk HPV test lies in the need for monitoring and potential treatment of any associated lesions, as well as counseling regarding sexual health and prevention strategies. It is crucial for healthcare providers to document the context of the test, including any symptoms, risk factors, and follow-up plans, to ensure accurate coding and appropriate patient management.
Documentation should include the reason for testing, results, and any associated symptoms or lesions.
Routine screening for HPV in patients with risk factors, follow-up after abnormal findings.
Consider the patient's sexual history and any previous HPV-related treatments.
Acute care documentation should include the patient's presenting symptoms and the rationale for HPV testing.
Patients presenting with anal warts or other symptoms suggestive of HPV infection.
Rapid assessment and documentation are crucial in emergency settings.
Used when testing for HPV types in patients with anal lesions or for screening.
Document the reason for the test and any associated findings.
Internal medicine and gynecology may frequently order this test.
A positive low-risk HPV test indicates the presence of low-risk HPV types, which are generally associated with benign conditions like genital warts. It does not indicate a risk for cancer but may require monitoring and treatment of any associated lesions.
